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Abstract
 
Experimental allergic encephalitis (EAE) is considered by many to be a model for human mul-
tiple sclerosis. Intraperitoneal inoculation of mice with 
 
Chlamydia pneumoniae
 
, after immuniza-
tion with neural antigens, increased the severity of EAE. Accentuation of EAE required live in-
fectious 
 
C. pneumoniae
 
, and the severity of the disease was attenuated with antiinfective
therapy. After immunization with neural antigens, systemic infection with 
 
C. pneumoniae
 
 led to
the dissemination of the organism into the central nervous system (CNS) in mice with accentu-
ated EAE. Inoculation with 
 
Chlamydia trachomatis
 
 did not worsen EAE and infectious organisms
were not seen in the CNS. These observations suggest that dissemination of 
 
C. pneumoniae
 
 re-
sults in localized infection in CNS tissues in animals with EAE. We propose that infection of
the CNS by 
 
C. pneumoniae
 
 can amplify the autoreactive pool of lymphocytes and regulate the
expression of an autoimmune disease.
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Introduction
 
Chlamydia pneumoniae
 
 belongs to a family of intracellular
organisms that typically causes a self-limiting respiratory in-
fection (1). More recently, 
 
C. pneumoniae
 
 has been linked
to a number of chronic human diseases including those that
involve the central nervous system (CNS; reference 2). In-
fections are known to play a role in the development and
progression of a number of autoimmune diseases, and we
have suggested that multiple sclerosis (MS) may be linked
to infections with 
 
C. pneumoniae
 
 (3–7).
Although the etiology of MS is not known, clinical
and pathologic observations suggest a close interplay be-
tween an infectious agent(s) and an autoimmune re-
sponse to myelin antigens in the development of the
disease (8, 9). Epidemiologic studies have implicated en-
vironmental factors and most likely infectious agents as a
necessary element in the development of MS (10). The
autoimmune basis for MS stems from similarities be-
tween MS and the animal model, EAE (11). In view of
the possible association between chlamydial infection and
the development of MS, we examined the effect of sys-
temic infection of 
 
C. pneumoniae
 
 on the development
and progression of EAE.
 
Materials and Methods
 
Animals and Reagents.
 
Female SJL/J and C57BL/6 mice
were purchased from The Jackson Laboratory. Guinea pig my-
elin basic protein (MBP) and mouse spinal cord homogenate was
prepared as described previously and myelin oligodendrocyte
protein
 
 (
 
MOG) peptide (p35–55: MEVGWYRSPFSRVVH-
LYRNGK) was synthesized by Genemed Synthesis, Inc. Fluoro-
phenicol was a gift from Dr. F. DeGraves, University of Auburn,
Auburn, AL. IFN-
 
 
 
 was measured by a commercial kit obtained
from R&D Systems. Concentrated 
 
C. pneumoniae
 
 elementary
bodies were obtained by growing 
 
C. pneumoniae
 
 (VR-1310;
American Type Culture Collection) and 
 
C. trachomatis
 
 (HAR13;
American Type Culture Collection) on a monolayer of HL cells.
The number of infectious forming units of chlamydial bodies
were estimated using the HL indicator cell line. The GD-11
strain of 
 
S. flexnerii
 
, a gift from J. Bright (Vanderbilt Medical
Center, Nashville, TN), was grown in soft agar. Heat killed 
 
C.
pneumoniae
 
 was prepared by boiling the organism in a water bath
for 5 min.
 
Lymphocyte Proliferation Assay.
 
Lymphocytes isolated from
draining lymph node cells were cultured in RPMI 1640 com-
plete medium in a 96-well microtiter plate under the atmosphere
of 5% CO
 
2
 
 and 95% air at 37
 
 
 
C, and the proliferation assay was
done as described previously (12).
 
Induction and Evaluation of EAE.
 
Active and adoptively trans-
ferred EAE and the clinical scoring of paralyzed mice was done
as described previously (12, 13). To examine the effect of
 
chlamydial infection on EAE, mice were injected with live 
 
C.
pneumoniae
 
 or 
 
C. trachomatis
 
 organisms. 0.5 
 
 
 
 10
 
6
 
 infectious
units (in 0.5 ml of PBS) intraperitoneally, 7 d after receiving the
first immunization.
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Immunohistochemical Localization of Chlamydial Antigens in CNS
Tissue of Mice with EAE.
 
The spinal cords were isolated from
the mice after perfusion with 4% paraformaldehyde in PBS on
day 18, fixed in 10% formalin, and embedded in paraffin. The
presence with 
 
C. pneumoniae
 
 antigens in the sections was de-
tected by immunohistochemistry using anti-chlamydial LPS anti-
body (mAB 807; Chemicon) following the protocol for the
M.O.M. mouse blocking kit (Vector Laboratories). Using anti-
gen retrieval techniques the spinal cord sections were incubated
with mAB 807 (recognizes all chlamydial LPS), was added at a
dilution of 1:750, and placed on a rocking platform overnight at
4
 
 
 
C.) The slides were then washed and biotin conjugated goat
anti–mouse antibody was added and the color developed using
the Envision kit (DakoCytomation). Anti 
 
Escherichia coli
 
 LPS an-
tibody (Fitzgerald Industries) and isotype matched IgG2a anti-
bodies (Sigma-Aldrich) were used as control antibodies in all the
staining procedures.
 
Isolation of Total RNA and Semiquantitative RT-PCR of Chlamyd-
ial Antigens.
 
After perfusion with PBS, spinal cords from mice
were collected, and total RNA extracted using TRI Reagent
(Sigma-Aldrich) in accordance with manufacturer’s protocol.
The following sense and antisense oligonucleotide PCR primers
were used: 
 
C. trachomatis
 
 16S RNA, 5
 
 
 
-ATT TGG GCA TCC
GAG TAA CG (sense) and 5
 
 
 
 CCA CGC GGT ATT AAC
CGT CT,
 
 C. pneumoniae
 
 16S RNA, 5
 
 
 
-GCT AAT ACC GAA
TGT AGT GTA A (sense) and 5
 
 
 
-ATC TAT CCT CTA GAA
AGA TAG TT, and GAPDH, 5
 
 
 
-TGA AGG TCG GTG TGA
ACG GAT TTG GC (sense) and 5
 
 
 
-CAT GTA GGC CAT
GAG GTC CAC CAC. 4 
 
 
 
g of total RNA was reverse tran-
scribed to cDNA using GeneAmp RNA PCR kit with oligo
d(T)
 
16
 
 primers (Roche). PCR amplification of each cDNA target
was performed along with GAPDH, which served as an internal
control for RNA quantity. Each PCR reaction contained 5 
 
 
 
l of
cDNA, 2 
 
 
 
l of 10
 
 
 
 PCR buffer (Perkin Elmer), 1 
 
 
 
l of 25 mM
MgCl
 
2
 
, 0.5 
 
 
 
l of each dNTP (10 mM), 0.5 
 
 
 
l of sense and anti-
sense target gene-specific primers (50 pmole/
 
 
 
l), 0.25 
 
 
 
l Ampli-
 
Taq
 
 DNA polymerase (5 U/
 
 
 
l) (PerkinElmer), and 13.75 
 
 
 
l of
nuclease-free H
 
2
 
O, and was performed in PTC-200 Peltier Ther-
mal Cycler (MJ Research, Inc.). PCR products were resolved on
1.5% agarose in TAE containing 0.5 
 
 
 
g/ml of ethidium bromide
and visualized under UV light.
 
Results
 
Worsening of EAE in Mice Infected with C. pneumoniae.
C. pneumoniae
 
 infection in mice was induced by intraperi-
toneal inoculation of infectious elementary bodies after the
second immunization with mouse spinal cord homogenate
(MSCH). Control mice received equal numbers of infec-
tious 
 
C. trachomatis
 
 or an equal number of colony forming
units of 
 
S. flexnerii
 
 (GD-11 strain). As shown in Fig. 1 A,
mice immunized with MSCH and injected with live 
 
C.
pneumoniae
 
 had a mean maximal disease severity score of
3.1, while those that received PBS, 
 
C. trachomatis
 
 or 
 
S. flex-
nerii
 
, had a mean maximal clinical score of 1.8, 2.1, and 1.2,
respectively (P 
 
  
 
0.05). To determine if enhancement of
EAE was specific to the immunogen, MSCH, we exam-
ined the effect of 
 
C. pneumoniae
 
 infection in MOGp35–55
induced EAE. The mean clinical score in mice that re-
ceived live 
 
C. pneumoniae
 
 after immunization with MOG
p35–55 was 2.3; in contrast, the mean clinical score in ve-
hicle treated mice was 1.3, suggesting that the effect of 
 
C.
pneumoniae
 
 infection on EAE was not specific to the immu-
nizing antigen (Fig. 1 B). A comparison of viable (i.e., in-
fectious) elementary bodies with heat-killed (i.e., noninfec-
Figure 1. Effect of C. pneumoniae infection on the development of
EAE. (A) Active EAE in SJL/J female mice was induced by immunization
with MSCH in complete Freund’s adjuvant. On day 7 animals were in-
jected intraperitoneally with either vehicle ( , n   6), live C. pneumoniae
( , n   6) C. trachomatis ( , n   6) (0.5   106 IFU) or S. flexnerii ( ,
n   6) 0.5   106 colony forming units (C. pneumoniae vs. vehicle/C. tra-
chomatis, P   0.05). (B) Active EAE in C57BL/6 female mice was in-
duced by immunization with MOG p35–55. On day 7, animals were in-
jected intraperitoneally with either vehicle ( ) or 0.5   106 IFU of live
C. pneumoniae ( ) (C. pneumoniae vs vehicle, P   0.05; n   5). (C) Ac-
tive EAE in SJL/J female mice was induced as described in (A), and in-
fected with either vehicle ( ) or 0.5   106 IFU of live ( ) or heat-killed
C. pneumoniae ( ) (live vs vehicle/heat-killed, P   0.01; n   6). (D) Ac-
tive EAE in SJL/J female mice was induced as described in (A), and in-
fected with various dose of live C. pneumoniae: 0 IFU ( ), 5   103 IFU
( ), 5   104 ( ) and 5   105 IFU ( ) (n   6). (E) Passive EAE in SJL/J
mice following adoptive transfer of MBP-reactive lymphocytes. The ani-
mals received either live C. pneumoniae ( ), heat killed C. pneumoniae
( ), or vehicle alone ( ), (live vs vehicle/heat-killed, P   0.05; n   10).
Concentrated C. pneumoniae elementary bodies are obtained by growing
C. pneumoniae (VR-1310; American Type Culture Collection) and C.
trachomatis (HAR13; American Type Culture Collection) on a monolayer
of HL cells. Y axis represents mean clinical severity scores of EAE.1641 Du et al. Brief Definitive Report
tious) elementary bodies revealed that worsening of EAE
requires viable C. pneumoniae organisms (Fig. 1 C). Also,
worsening of EAE was dependent upon the actual number
of infectious elementary bodies in the intraperitoneal inoc-
ulum (Fig. 1 D). To establish whether the effect of C. pneu-
moniae infection on EAE was seen after T cell priming to
neural antigens, we examined infection with C. pneumoniae
after adoptive transfer of MBP reactive T cells. As shown in
Fig. 1 E, mean clinical score of mice that received live C.
pneumoniae and MBP primed lymphocytes was 3.6. In mice
that received vehicle or heat killed C. pneumoniae the mean
clinical scores were 2.6 and 2.4, respectively. The sum of
these results show that live C. pneumoniae can worsen EAE
induced by different neural antigens and also after priming
of T cells.
Presence of Metabolically Active Elementary Bodies of C. pneu-
moniae in CNS of Mice with Worsening of EAE after Infection
with Live C. pneumoniae. Three groups of mice (five/
group) were immunized with MSCH in CFA and infected
with either C. pneumoniae or C. trachomatis on day 7. The
third group of mice was left untreated. 18 d after immuni-
zation, the mice were killed, and an RT-PCR analysis of
RNA obtained from the spinal cord were performed. As
shown in Fig. 2, all four mice from which RNA was avail-
able showed an RT-PCR signal for the presence of repli-
cating C. pneumoniae. None of the mice infected with C.
trachomatis showed a signal to primers that were specific for
the C. trachomatis 16sRNA gene. These studies suggest that
C. pneumoniae but not C. trachomatis is capable of infecting
the CNS in mice with EAE.
To further prove that an inflammatory response in the
brain was necessary in order to set an infection with C.
pneumoniae, naive mice were infected with either C. pneu-
moniae or C. trachomatis and the presence of chlamydia in
the CNS was examined. As shown in Table I, the RT-
PCR signal for the 16S gene of C. pneumoniae and C. tra-
chomatis was noted in the spleen, lung, and lymph nodes of
naive mice, infected intraperitoneally with either C. pneu-
moniae or C. trachomatis. An RT-PCR signal for the 16S
gene was not seen in the CNS in mice infected with ei-
ther C. trachomatis or C. pneumoniae on days 3, 7, and 11
after infection.
Immunohistochemical Analysis for the Presence of C. pneumo-
niae in CNS of Mice with EAE and Infected with C. pneu-
moniae. To directly demonstrate the presence of C. pneu-
moniae in the CNS, spinal cords were obtained from mice
which were infected with C. pneumoniae and induced to
develop EAE. Spinal cords were stained with anti-chlamyd-
ial antibodies using standard immunohistochemical tech-
niques. Intracellular staining of perivascular mononuclear
and CNS parenchymal cells with anti-chlamydial antibod-
ies was seen in at least one section of all four mice exam-
ined (Fig. 3, c and d). No staining of elementary bodies
were seen in mice immunized with MSCH and inoculated
with C. trachomatis (Fig. 3 b). The monoclonal antibody
807 recognizes LPS and MOMP antigens of both C. tra-
chomatis and C. pneumoniae. No staining of chlamydial anti-
gens was seen in mice with EAE and infected with C. pneu-
moniae after incubation with an irrelevant control antibody
(anti–E. coli LPS antibody, unpublished data). These results
corroborate our observations on RT-PCR and offer direct
evidence of infection by C. pneumoniae of the CNS.
Treatment if EAE Mice Infected with C. pneumoniae with
Fluorphenicol. If infection with C. pneumoniae directly af-
fects the development of EAE we predicted that antibiotic
therapy aimed at C. pneumoniae would attenuate the dis-
Figure 2. RT-PCR analysis of C. pneumoniae gene transcription in the
CNS of mice with EAE. Mice were immunized with MSCH and infected
with either C. pneumoniae or C. trachomatis as described in Fig. 1 A. Mice
were killed on day 18 and total RNA was isolated from PBS-perfused spi-
nal cords, and then analyzed for the presence of mRNA of C. pneumoniae
16S RNA gene by RT-PCR. Lanes 1–5, uninfected mice immunized
with MSCH alone; lanes 6–10 mice infected with C. trachomatis and im-
munized with MSCH; lanes 11–14 mice infected with C. pneumoniae and
immunized with MSCH. Lane 15 internal negative control, lane 16 inter-
nal positive control for each of the primers. Arrows indicate the size of
PCR product. Top panel, RT-PCR performed with primers for
16SRNA of C. pneumoniae, middle panel RT-PCR performed with prim-
ers for 16SRNA of C. trachomatis, and bottom panel, GAPDH primers.
Table I. Systemic Dissemination of C. pneumoniae and C. trachomatis after Intraperitoneal Injection of Naive Mice
D3
spleen
D3
LN
D3
lung
D3
brain
D7
spleen
D7
LN
D7
lung
D7
brain
D11
spleen
D11
lung
D11
brain
C. trachomatis 2/2 2/2 ND 0/2 2/2 2/2 ND 0/2 1/2 ND 0/2
C. pneumoniae 2/2 ND 2/2 0/2 0/2 ND 2/2 0/2 1/2 2/2 0/2
SJL/J mice were injected intraperitoneally (0.5   106) with either live C. trachomatis or C. pneumoniae organisms. Spleen, lung, mesenteric lymph
nodes (LN), and brain were harvested on day 3, 7, and 11. RT-PCR for the presence of infectious organisms was performed using 16S primers for
C. pneumoniae and C. trachomatis, respectively. ND, not done.1642 C. pneumoniae and CNS Demyelination
ease. Treatment with Fluorophenicol reduced the severity
of EAE. The mean maximal clinical score decreased from
2.3 in untreated mice to 1.4 in mice that received Fluo-
rophenicol. The severity of EAE in antibiotic treated mice
was similar to mice immunized with MSCH alone. Fluo-
rophenicol did not affect the course of EAE in mice immu-
nized with MSCH that did not receive intraperitoneal in-
oculation with infectious C. pneumoniae elementary bodies
suggesting that the effect was unlikely to be due to any im-
munomodulatory effect of the antibiotic (Fig. 4).
Activation of MBP-reactive Lymphocytes after Infection with
C. pneumoniae or C. trachomatis. We next examined if
worsening of EAE in mice inoculated with C. pneumoniae
was due to an increase in activation of MBP reactive Th1
cells. We determined the effect of in vivo infection with
live chlamydia on lymphocyte proliferation and IFN-  pro-
duction to MBP in, in vitro cultures. Proliferation counts
to MBP, obtained from mice immunized with MBP and
infected with C. pneumoniae increased from background
levels of 4,305   120 to 28,854   1,154 cpm to in the
presence of 50  g/ml of MBP. Background counts in C.
trachomatis mice was 4,196   1,492 cpm, which increased
to 19,308   932 cpm in the presence of MBP. In unin-
fected mice, proliferative response to MBP increased from
3,916   186 to 15,068   815, in the presence of MBP.
The proliferative response to MBP was higher in both C.
pneumoniae and C. trachomatis infected mice when com-
pared with uninfected controls suggesting that concurrent
infection with chlamydia can amplify an autoimmune re-
sponse. A proliferative response to MBP was not seen in
mice infected with C. pneumoniae alone, suggesting a lack
of cross reactivity between C. pneumoniae antigens and
MBP (Fig. 5). IFN-  levels in lymphocyte culture superna-
tants were similarly higher in C. pneumoniae (1,020 pg/ml)
and C. trachomatis infected mice (950 pg/ml) when com-
pared with uninfected mice (612 pg/ml; P   0.05, Fig. 5).
These observations suggest that unlike its different effects
on paralytic EAE, both C. trachomatis and C. pneumoniae in-
Figure 3. Immunohistochemical detection of chlamydial antigens in
the spinal cords of mice with EAE. (a) Presence of chlamydial antigens in
lung tissue from Balb/c mice, infected intranasally with C. pneumoniae
and stained with Mab 807. (b) Representative areas of perivascular infil-
tration/inflammation in C. trachomatis-infected mice with EAE, showing
no staining with Mab 807. (c and d) Representative areas of perivascular
lymphocytic inflammation of C. pneumoniae-infected mice with EAE, in-
dicating staining with Mab 807 (arrows).
Figure 4. Effect of Fluorophenicol on severity of EAE in mice infected
with C. pneumoniae. EAE was established as described in Fig. 1 A. Be-
ginning on day 7, till day 18, C. pneumoniae-infected EAE mice were ei-
ther treated with Fluorophenicol (subcutaneous 5 mg/kg daily) ( ) or
vehicle ( ) (treated vs untreated, P   0.01; n   12). Uninfected mice
immunized to induce EAE were treated with Fluorophenicol (  subcuta-
neous 5 mg/kg daily) or untreated ( , n   12).
Figure 5. Effect of infection C. pneumoniae and C. trachomatis on the
development of an immune response to MBP. SJL/J female mice were
immunized with MBP and infected with chlamydial organisms as de-
scribed in Fig. 1 A. (Top) Proliferative response of splenocytes to MBP in
infected and uninfected mice. The data represents the mean value and SD
(standard deviation) of [3H]thymidine uptake (CPM) of triplicate determi-
nation at each point. (Bottom) IFN-  production in culture supernatants
in response to MBP. The levels of IFN-  in supernatants were measured
by ELISA at 48 and 72 h, respectively. The data represents the mean and
standard value (SD) of triplicate determinations at each time point from a
representative three experiments (CT, C. trachomatis; CP, C. pneumoniae).1643 Du et al. Brief Definitive Report
fections are capable of enhancing T cell proliferation and
IFN-  production in response to MBP over that seen in
uninfected controls.
Discussion
This study shows the effect of live C. pneumoniae infec-
tion on the amplification of the autoimmune disease after
immunization with three different neural antigens (MSCH,
MBP, and MOG). The accentuation of EAE was seen in
the setting of direct infection of the CNS by C. pneumo-
niae. A causal association between C. pneumoniae infection
and accentuated EAE can be inferred not only from the di-
rect presence of replicating organism in the CNS, but also
from the attenuation of EAE after therapy with Fluoropheni-
col. We believe that infection of C. pneumoniae in the CNS
is a requisite for worsening of EAE. Systemic infection
with C. trachomatis enhanced the in vitro proliferative re-
sponse to MBP that were higher than controls. Unlike C.
pneumoniae, C. trachomatis did not infect the CNS in mice,
which we believe is important to cause worsening of EAE.
One mechanism by which infections can potentially in-
duce autoimmune disease is through molecular mimicry.
After immunization with chlamydial peptides that show
homology with MBP, rats developed severe EAE (14). In
view of the link between chlamydial antigens and heart dis-
ease, sequence homology between heart myosin and C.
pneumoniae antigens were screened and mice were immu-
nized with antigens that showed homology with myocar-
dial antigens (15). These two studies showed that cross re-
active epitopes between chlamydial and self antigens are
capable of inducing different forms of autoimmune disease.
Our study did not show evidence of molecular mimicry
between C. pneumoniae and neural antigens in SJL mice.
Mice infected with C. pneumoniae alone did not show a
lymphocyte proliferative response to MBP. Although we
cannot fully exclude the expansion of autoreactive T cells
that cross-react with C. pneumoniae, we think this to be un-
likely. Animals showed worsening of EAE induced by
three different classes of encephalitogenic antigens, MBP,
MOG, and MSCH. It is unlikely that molecular mimicry is
present between chlamydial antigens and three different
neural antigens.
Infectious agents are well known to rapidly expand the
pool of immune cells that recognize the invading pathogen.
An increase in population of T cells that recognize other
antigens including those that react to self-proteins may oc-
cur consequent to the secretion of cytokines and may be
sufficient to cause disease (16). In mouse hepatitis model of
CNS infection, prominent demyelination mediated by
CD8 T cells was seen in mice in the absence of cognate an-
tigen in the CNS, suggesting that demyelination did not
require the presence of antigen-specific T cells (17). In the
mouse keratitis model induced by HSV-1, both antigenic
mimicry and bystander activation are thought to be respon-
sible for tissue injury. In trying to reconcile the views of
molecular mimicry and bystander activation in autoimmu-
nity, it was proposed that these two processes may not nec-
essarily be exclusive and may depend upon the circulating
levels of autoreactive cells (18).
There has been considerable interest in the role of infec-
tious agents in the development of MS. We have proposed
that chlamydial infections should be considered as a poten-
tial candidate agent in MS (2). Our current studies suggest
that C. pneumoniae can infect the CNS in mice. A number
of case reports have suggested that C. pneumoniae can cause
acute CNS infections in humans (19, 20). Persistence of C.
pneumoniae in the CNS is likely to provide an environment
which can lead to the activation of autoreactive T cells and
contribute to the pathogenesis of a chronic disease such as
MS. The lack of worsening of EAE in mice receiving in-
traperitoneal inoculations of infectious C. trachomatis ele-
mentary bodies suggests that direct infection of CNS tis-
sues is necessary to enhance EAE. C. pneumoniae and C.
trachomatis disseminate to lymphoid organs and lung after
parental administration of the pathogen (21–23). We did
not observe dissemination of C. pneumoniae to the CNS in
naive mice. We propose that infection of the CNS is a
necessary for accentuation of EAE which may be facilitated
in the presence of an ongoing CNS inflammation. We
suggest that a similar scenario may occur in MS, in which a
ubiquitous pathogen may amplify an autoimmune re-
sponse. We predict that if an infectious agent can persist
and amplify an immune response, it can modify the ex-
pression of a T cell–mediated autoimmune disease in an
organ specific manner. A direct interplay between an in-
fectious agent and autoimmunity is also likely to have im-
mediate therapeutic implications.
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